1. 577 Engineered non-pathogenic synthetic biotic producing L-arginine synergize with PD-1-based cancer immunotherapy. (10th December 2020) Authors: Canale, Fernando; Basso, Camilla; Li, Ning; Sokolovska, Anna; Perotti, Michela; James, Michael; Jin, Wenjie; Theurillat, Jean-Philippe; Leventhal, Daniel; West, Kip; Lora, Jose; Sallusto, Federica; Geiger, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 577 Engineered non-pathogenic synthetic biotic producing L-arginine synergize with PD-1-based cancer immunotherapy. (9th November 2020) Authors: Canale, Fernando; Basso, Camilla; Li, Ning; Sokolovska, Anna; Perotti, Michela; James, Michael; Jin, Wenjie; Theurillat, Jean-Philippe; Leventhal, Daniel; West, Kip; Lora, Jose; Sallusto, Federica; Geiger, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut. Issue 1 (December 2017) Authors: Romagnani, Andrea; Vettore, Valentina; Rezzonico-Jost, Tanja; Hampe, Sarah; Rottoli, Elsa; Nadolni, Wiebke; Perotti, Michela; Meier, Melanie; Hermanns, Constanze; Geiger, Sheila; Wennemuth, Gunther; Recordati, Camilla; Matsushita, Masayuki; Muehlich, Susanne; Proietti, Michele; Chubanov, Vladimir... Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗